Central Nervous System Neoplasms
"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Descriptor ID |
D016543
|
| MeSH Number(s) |
C04.588.614.250 C10.551.240
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".
This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in this website by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 2 | 0 | 2 |
| 2007 | 3 | 1 | 4 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 1 | 3 |
| 2010 | 7 | 0 | 7 |
| 2011 | 2 | 1 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 5 | 0 | 5 |
| 2015 | 4 | 0 | 4 |
| 2016 | 5 | 2 | 7 |
| 2017 | 10 | 0 | 10 |
| 2018 | 5 | 1 | 6 |
| 2019 | 12 | 1 | 13 |
| 2020 | 5 | 0 | 5 |
| 2021 | 10 | 0 | 10 |
| 2022 | 6 | 0 | 6 |
| 2023 | 8 | 0 | 8 |
| 2024 | 5 | 1 | 6 |
| 2025 | 11 | 0 | 11 |
| 2026 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles.
-
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. Blood Adv. 2026 Jun 23; 10(12):4184-4192.
-
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol. 2026 Apr 17; 177(3).
-
Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. J Neurooncol. 2026 Feb 25; 177(1).
-
Burden of Central Nervous System Cancer in the United States, 1990-2021. JAMA Neurol. 2026 Jan 01; 83(1):35-48.
-
Neurotoxicity in central nervous system tumors treated with CAR T cell therapy: a review. J Neurooncol. 2025 Oct 31; 176(1):60.
-
Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort. J Med Genet. 2025 Oct 20; 62(11):720-723.
-
Translational advancement of immunotherapeutics against pediatric central nervous system tumors. Adv Cancer Res. 2025; 167:327-358.
-
The promise of immunotherapy for central nervous system tumours. Nat Rev Immunol. 2026 Mar; 26(3):213-229.
-
Years of life lost due to central nervous system tumor subtypes in the United States. Neuro Oncol. 2025 Oct 01; 27(10):2738-2746.
-
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement. Blood Adv. 2025 Aug 26; 9(16):4081-4089.